日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib

MiR-4649-5p 通过与 PIP5K1C 直接相互作用,在三阴性乳腺癌中充当肿瘤抑制 microRNA,从而增强 AKT 抑制剂 capivasertib 的生长抑制作用

Katharina Jonas, Felix Prinz, Manuela Ferracin, Katarina Krajina, Barbara Pasculli, Alexander Deutsch, Tobias Madl, Beate Rinner, Ondrej Slaby, Christiane Klec, Martin Pichler

MiR-4646-5p Acts as a Tumor-Suppressive Factor in Triple Negative Breast Cancer and Targets the Cholesterol Transport Protein GRAMD1B

MiR-4646-5p 可作为三阴性乳腺癌的肿瘤抑制因子,并靶向胆固醇转运蛋白 GRAMD1B

Katharina Jonas, Felix Prinz, Manuela Ferracin, Katarina Krajina, Alexander Deutsch, Tobias Madl, Beate Rinner, Ondrej Slaby, Christiane Klec, Martin Pichler

Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells

纳摩尔浓度的乌巴因对胆道癌细胞具有细胞毒性

Christian Mayr, Tobias Kiesslich, Dino Bekric, Marlena Beyreis, Michael Kittl, Celina Ablinger, Elen Neureiter, Martin Pichler, Felix Prinz, Markus Ritter, Daniel Neureiter, Martin Jakab, Heidemarie Dobias

MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response

MicroRNA 模拟物可通过触发抗病毒干扰素反应来扭曲生理性 microRNA 对免疫检查点的影响

Felix Prinz, Katharina Jonas, Amar Balihodzic, Christiane Klec, Andreas Reicher, Dominik Andreas Barth, Jakob Riedl, Armin Gerger, Tobias Kiesslich, Christian Mayr, Beate Rinner, Julia Kargl, Martin Pichler

MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms

MiR-200c-3p 通过 ZEB1 独立机制调节胆道癌的顺铂耐药性

Florian Posch, Felix Prinz, Amar Balihodzic, Christian Mayr, Tobias Kiesslich, Christiane Klec, Katharina Jonas, Dominik A Barth, Jakob M Riedl, Armin Gerger, Martin Pichler